CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma
Authors
Keywords
Hepatocellular carcinoma, HBV, Sorafenib resistance, Chemokine, CCL22 signaling
Journal
PHARMACOLOGICAL RESEARCH
Volume 157, Issue -, Pages 104800
Publisher
Elsevier BV
Online
2020-04-08
DOI
10.1016/j.phrs.2020.104800

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.